The science of Microdosing GLP-1 Broad clinical potential: Commonly used to treat type 2 diabetes and weight management, GLP-1 medications act on GLP-1 receptors located in the brain, gut, and immune system, impacting multiple biomarkers. Recent studies have begun exploring low doses of GLP-1 medications for broader health goals beyond glucose control and weight loss. Emerging research in healthspan and longevity: In a series of studies, low doses of GLP-1 receptor agonists were shown to modulate inflammatory pathways, support mitochondrial function, and lower the risk of cognitive decline in study participantsgiving Microdosing GLP-1 promising potential for extending healthspan
151,152 As sensitive DNA damage sensors, PAPRs are recruited and immediately activated by DNA breaks
(Glutathione) (Antioxidant) (Free Radical)
This material is not intended to diagnose, treat, cure, or prevent disease.
Early studies suggest it might have some health benefits, but it's not clear exactly how it works
